Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (year values)

2016 2017 2018 2019 2020   LTM ?
EV/EBITDA ? 0.80 0.36 1.13 -11.8 -3.20   -9.01
Changes by years, y/y, % -55% +211% -1 148% -73%    

Constellation Pharmaceuticals. EV/EBITDA

Constellation Pharmaceuticals. EV/EBITDA, changes, %

Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (quarter values)

2020Q1 2020Q2 2020Q3 2020Q4 2021Q1   LTM ?
EV/EBITDA ? -11.0 -8.09 -4.61 -7.75 -5.35   -9.01
Changes by years, y/y, % +193% +160% +244% -59% -51%    
Changes by quarters, q/q, % -42% -26% -43% +68% -31%    

Constellation Pharmaceuticals. EV/EBITDA

Constellation Pharmaceuticals. EV/EBITDA, changes, y/y, %

Constellation Pharmaceuticals. EV/EBITDA, changes, q/q, %